In the present work, quantification of DPP-IV enzymatic activity and sCD26 in serum as well as quantification of CD26 on the cell surface of different CD4 T cell subsets has been studied in RA patients undergoing different treatments. This evidence concerns the gene DPP4 and rheumatoid arthritis.